DigestRedComo funciona
Red
/
Empresas
Ta
No verificado

Taiho Oncology, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosOncologíaSalud

5 Comunicados de prensa

Ver todos los comunicados de prensa
03/06/2026
Industria
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Taiho Oncology Announces New England Journal of Medicine Publication of First All-Oral Regimen in Newly Diagnosed Acute Myeloid Leukemia
Fuente
Taiho Oncology, Inc.
Editor
Business Wire
1.00
0
14/05/2026
Multimedia
Industria
Ciencia
Higiene alimentaria
Medicina - Varios
Biotecnología
Sanidad
Farmacéutica
Salud
Oncología
U.S. FDA Approves INQOVI® in Combination with Venetoclax, the First All-Oral Combination Treatment for Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction Chemotherapy
Fuente
Taiho Oncology, Inc.
Editor
Business Wire
1.00
0
28/04/2026
Multimedia
Mercado laboral
Industria
Oncología
Salud
Higiene alimentaria
Medicina - Varios
Farmacéutica
Biotecnología
U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Fuente
Taiho Oncology, Inc.
Editor
Business Wire
1.00
0
28/01/2026
Ciencia
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Sanidad
Oncología
Mercado laboral
Taiho Oncology Appoints Peter Melnyk as President & Chief Executive Officer
Fuente
Taiho Oncology, Inc.
Editor
Business Wire
1.00
0
20/01/2026
Oncología
Salud
Ciencia
Farmacéutica
Biotecnología
Mercado laboral
Peter Melnyk Joins Taiho Oncology as President & Chief Operating Officer
Fuente
Taiho Oncology, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0